BioVie Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioVie Inc. stock issued during period, value, other for the quarter ending 2020-06-30 was $0.00.
- BioVie Inc. stock issued during period, value, other for the quarter ending 2020-03-31 was $13.49K.
- BioVie Inc. stock issued during period, value, other for the quarter ending 2019-09-30 was $10.07M.
- BioVie Inc. stock issued during period, value, other for fiscal 2020 was $13.49K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $13.49K 10-K · filed 2021-08-30 |
| 2020-03-31 | $13.49K 10-Q · filed 2021-05-10 | |
| 2019-09-30 | $10.07M 10-Q · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |